These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22119584)

  • 21. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
    Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
    Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
    J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
    Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
    PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving malaria control in West Africa: interruption of transmission as a paradigm shift.
    Doumbia SO; Ndiaye D; Koita OA; Diakité M; Nwakanma D; Coulibaly M; Traoré SF; Keating J; Milner DA; Ndiaye JL; Sene PD; Ahouidi A; Dieye TN; Gaye O; Okebe J; Ceesay SJ; Ngwa A; Oriero EC; Konaté L; Sy N; Jawara M; Faye O; Kéita M; Cissé M; Sogoba N; Poudiougou B; Diawara S; Sangaré L; Coulibaly T; Seck I; Abubakar I; Gomis J; Mather FJ; Sissako A; Diarra A; Kandeh B; Whalen C; Moyer B; Nnedu O; Thiero O; Bei AK; Daniels R; Miura K; Long CA; Fairhurst RM; Duraisingh M; Muskavitch MA; D'Alessandro U; Conway DJ; Volkman SK; Valim C; Wirth DF; Krogstad DJ
    Acta Trop; 2012 Mar; 121(3):175-83. PubMed ID: 22142790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent preventive treatment against malaria: an update.
    Gosling RD; Cairns ME; Chico RM; Chandramohan D
    Expert Rev Anti Infect Ther; 2010 May; 8(5):589-606. PubMed ID: 20455687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
    Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
    Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
    Bwire GM; Mikomangwa WP; Kilonzi M
    BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Trop Med Int Health; 2006 Jul; 11(7):992-1002. PubMed ID: 16827700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
    Cissé B; Sokhna C; Boulanger D; Milet J; Bâ el H; Richardson K; Hallett R; Sutherland C; Simondon K; Simondon F; Alexander N; Gaye O; Targett G; Lines J; Greenwood B; Trape JF
    Lancet; 2006 Feb; 367(9511):659-67. PubMed ID: 16503464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
    Mockenhaupt FP; Bedu-Addo G; Eggelte TA; Hommerich L; Holmberg V; von Oertzen C; Bienzle U
    J Infect Dis; 2008 Nov; 198(10):1545-9. PubMed ID: 18834303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.
    Tonga C; Kimbi HK; Anchang-Kimbi JK; Nyabeyeu HN; Bissemou ZB; Lehman LG
    PLoS One; 2013; 8(6):e65876. PubMed ID: 23762446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies.
    Griffin JT; Hollingsworth TD; Okell LC; Churcher TS; White M; Hinsley W; Bousema T; Drakeley CJ; Ferguson NM; Basáñez MG; Ghani AC
    PLoS Med; 2010 Aug; 7(8):. PubMed ID: 20711482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data.
    van Eijk AM; Hill J; Alegana VA; Kirui V; Gething PW; ter Kuile FO; Snow RW
    Lancet Infect Dis; 2011 Mar; 11(3):190-207. PubMed ID: 21273130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria control aimed at the entire population in KwaZulu-Natal negates the need for policies to prevent malaria in pregnancy.
    Tsoka-Gwegweni JM; Kleinschmidt I
    S Afr Med J; 2013 Jan; 103(3):172-5. PubMed ID: 23472694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of household ownership of bed nets in areas with and without artemisinin resistance containment measures in Myanmar.
    Maung TM; Oo T; Wai KT; Hlaing T; Owiti P; Kumar B; Shewade HD; Zachariah R; Thi A
    Infect Dis Poverty; 2018 Mar; 7(1):19. PubMed ID: 29571301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
    Huho BJ; Killeen GF; Ferguson HM; Tami A; Lengeler C; Charlwood JD; Kihonda A; Kihonda J; Kachur SP; Smith TA; Abdulla SM
    Malar J; 2012 Apr; 11():118. PubMed ID: 22513162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial.
    Corbel V; Akogbeto M; Damien GB; Djenontin A; Chandre F; Rogier C; Moiroux N; Chabi J; Banganna B; Padonou GG; Henry MC
    Lancet Infect Dis; 2012 Aug; 12(8):617-26. PubMed ID: 22682536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.